Why did VFX.AX stock fall sharply today?

VFX.AX stock fell due to heavy intraday selling, low market cap, and thin liquidity. Volume spiked to **67,444.00** shares versus average **12,809.00**, magnifying moves. No earnings surprise was reported; technical selling and weak fundamentals drove the drop.

What are the key support and resistance levels for VFX.AX stock?

Watch **support at A$0.05** (year low) and immediate resistance at **A$0.09** and **A$0.11**. A break below A$0.05 may accelerate downside, while sustained moves above A$0.09 would reduce short-term technical risk.

How does Meyka AI view VFX.AX stock?

Meyka AI rates VFX.AX **66.76 out of 100**, Grade **B** with a **HOLD** view. The grade balances weak cash flow and negative EPS against possible growth if the company wins telehealth contracts.

What price could VFX.AX stock reach according to forecasts?

Meyka AI's model projects **monthly A$0.09**, **quarterly A$0.20** and **yearly A$0.38013**. Compared with current **A$0.063**, the yearly forecast implies roughly **503.24%** upside. Forecasts are model projections, not guarantees.

AU Stocks

VFX.AX Visionflex Fpo (ASX) down 20.25% intraday 05 Mar 2026: watch A$0.05 support

ByDanny Kontos March 5, 2026March 5, 2026

VFX.AX stock fell 20.25% intraday on 05 Mar 2026, trading at A$0.063 as sellers accelerated on heavy volume. The drop pushed volume to 67,444.00 shares versus an average of 12,809.00, a relative volume of 5.27, signalling outsized trading. Visionflex Fpo (VFX.AX) is listed on the ASX in Australia and operates in the Healthcare sector. Investors are monitoring technical oversold signals and the company’s fragile fundamentals after weak trailing metrics and negative EPS, while short-term support sits near A$0.05